I-ONE® therapy

I-ONE® therapy: joint chondroprotection

I-ONE® therapy is a biophysical treatment for joint chondroprotection.

I-ONE® therapy is indicated for early stages of osteoarthritis and post-traumatic joint pathologies.

I-ONE® therapy effectively controls joint inflammation and protects articular cartilage from degeneration.

I-ONE® therapy alleviates pain associted with joint swelling reducing recovery time. 

I-ONE®  therapy was developed within the "C.R.E.S. study" (Cartilage Repair and Electromagnetic Stimulation), a large translational research focused on the chondroprotective effect.



Informative material

if_file-pdf_285666.png I-ONE® therapy Folder

if_file-pdf_285666.png I-ONE® therapy Technical Data Sheet

I-ONE® therapy complies with safety standards for medical electrical equipment EN 60601‐1.

I-ONE® therapy complies with the European Directive for Medical Devices 93/42/CEE and its revised version and it is CE0051 marked under the control of the Notification Body IMQ.

To grant efficacy and safety and in conformity to the EN 60601-1-11 standard, the therapy parameters are preset according to the pathology and can not, even unintentionally be modified by the patient.


The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2020